List view / Grid view
Novartis and the Bill & Melinda Gates Foundation have formed…
Novartis and the Bill & Melinda Gates Foundation have formed an alliance to advance the development of Novartis' drug candidate KDU731...
Novartis published clinical trial results in the New England Journal…
31 July 2014 | By Novartis
Novartis published clinical trial results in the New England Journal of Medicine showing that KAE609 (cipargamin), a novel and potent antimalarial drug candidate...
Novartis scientists have discovered a new drug target for treating…
28 November 2013 | By Novartis
Novartis scientists have discovered a new drug target for treating malaria...
